Analyst firms · B. Riley Securities · BCYC
B. Riley Securities BCYC price target and rating history
Bicycle Therapeutics plc (BCYC) · Health Care
B. Riley Securities rates Bicycle Therapeutics plc (BCYC) Neutral with a $28 price target, as of its latest action on Aug 7, 2024. It has published 4 rating actions on BCYC since September 2021, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $28
- Median target, all firms
- Too few
- Actions on BCYC
- 4
B. Riley Securities price target on BCYC
Every B. Riley Securities rating on BCYC
- Aug 7, 2024
- Sep 11, 2023
- Apr 13, 2022
- Sep 30, 2021
Questions about B. Riley Securities and BCYC
- What is B. Riley Securities's price target for BCYC?
- B. Riley Securities's latest stated price target for Bicycle Therapeutics plc (BCYC) is $28, from its action on Aug 7, 2024.
- What is B. Riley Securities's rating on BCYC?
- B. Riley Securities rates BCYC Neutral, a neutral rating, as of Aug 7, 2024.
- When did B. Riley Securities last change its view on BCYC?
- On Aug 7, 2024, B. Riley Securities downgrades to Neutral from Buy, price target $33 to $28.
More BCYC rating histories
All B. Riley Securities ratingsBCYC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.